Comparison of uptake of 99mTC-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines

European Journal of Nuclear Medicine

Volumn 23, Issue 10, 1996, Pages 1361-1366

  De Jong, Marion ^a   Bernard, Bert F ^a   Breeman, Wout A P ^a   Ensing, Geert ^b   Benjamins, Harry ^b   Bakker, Willem H ^a   Visser, Theo J ^a   Krenning, Eric P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Mallinckrodt Medical   (Netherlands)

Author keywords

MCF 7; Technetium 99m methoxyisobutylisonitrile; Technetium 99m Q12; Technetium 99m tetrofosmin; ZR 75

Indexed keywords

CELL PROTEIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; FURAN DERIVATIVE; ORGANOPHOSPHORUS COMPOUND; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M Q12;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CELL DENSITY; CELL GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; HEART MUSCLE; HUMAN; HUMAN CELL; IMAGING; ISOTOPE LABELING; RADIOACTIVITY; TEMPERATURE DEPENDENCE; TUMOR CELL LINE; ADENOCARCINOMA; BREAST TUMOR; CELL CULTURE; COMPARATIVE STUDY; FEMALE; SCINTISCANNING; TIME;

ADENOCARCINOMA; BREAST NEOPLASMS; FEMALE; FURANS; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0029665301     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01367592     Document Type: Article

References (17)

1. Jones AG, Abrams MG, Davison A, et al. Biological studies of a new class of technetium complexes: the hexakis (alkylisonitrile) technetium (II) cations. Int J Nucl Med Biol 1984; 11: 225-234.
2. Eackers FJ, Berman DJ, Maddahi J, et al. Technetium 99m hexakis 2 methoxyisobutyl isonitrile: human distribution, dosimetry, safety, and preliminary comparison to thallium 201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
3. Müller S, Guth-tougelides B, Creutzig H. Imaging of malignant tumours with Tc-99m-MIBI [abstract]. J Nucl Med 1987; 28: 562.
4. Müller S, Reiners C, Paas M, Guth-tougelidis B, Budach V, Konietzko N, Alberti W. Tc-99m-MIBI and Tl-2-1 uptake in bronchial carcinoma [abstract]. Eur J Nucl Med 1989; 30: 485.
5. Nyman R, Rehn S, Glimelius B, Hagberg H, Hemmingsson A, Jung B. Magnetic resonance imaging for assessment of treatment effects in mediastinal Hodgkin's disease. Acta Radiol 1987; 28: 145-151.
6. Coakley AJ, Kettle A, Wells CP, O'Doherty MJ, Collins R. Technetium-99m-sestamibi: a new agent for parathyroid imaging. Nucl Med Commun 1989; 10: 791-794.
7. 99mTcm-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994; 15: 604-612.
8. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994; 21: 432-436.
9. Piwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug-resistant P-glycoprotein with an organo-technetium complex. Cancer Res 1993; 53: 977-984.
10. m-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995; 16: 253-257.
11. Mansi L., Rambaldi PF, La Provitera A, Di Gregorio F, Procaccini E. Tc-99m tetrofosmin uptake in breast tumours. J Nucl Med 1995; 36: 83P.
12. Ballinger JR, Banneman J, Boxen I, Firby P, Berry BW, Moore MJ, Hartman NG. Accumulation of Tc-99m tetrofosmin in breast tumour cells in vitro: role of the multidrug-resistance P-glycoprotein. J Nucl Med 1995; 36: 202P.
13. Flamen P, Everaert H, Bossuyt A, Franken PR. Image analysis of Tc99-tetrofosmin in a one-day rest and dipyridamole stress myocardial SPECT imaging protocol. Intra-individual comparison with Tc99m-sestamibi. J Nucl Med 1995; 36: 24P.
14. Crankshaw CL, Marmion M, Burleigh BD, Deutsch E, Piwnica-Worms D. Non-reducible mixed ligand Tc(III)cations (Q-complexes) are recognized as transport substrates by the human multidrug resistance (MDR)P-glycoprotein. J Nucl Med 1995; 36: 130P.
15. Chiu ML, Kronange JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2 methoxyisobutyl isonitrile) technetium in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
16. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis-(alkylisonitril)-technetium-99m complexes. J Nucl Med 1990; 31: 1166-1167.
17. Delmon-moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50: 2198-2202.